DRUGS MADE IN AMER ACQ II CO UNIT 09/16/2030 is a security (CUSIP G2851K120) tracked across SEC portfolio filings. 15 institutional managers reported $41.4M on Form 13F as of 2026-06-30.
| Manager | Location | Value | Shares |
|---|---|---|---|
| LMR Partners LLP | LONDON, X0 | $20.1M | 2,000,000 |
| Westchester Capital Management, LLC | VALHALLA, NY | $5.0M | 502,914 |
| TIG Advisors, LLC | New York, NY | $5.0M | 500,000 |
| BlueCrest Capital Management Ltd | ST HELIER, Y9 | $2.5M | 250,000 |
| Verition Fund Management LLC | GREENWICH, CT | $2.5M | 250,000 |
| Clear Street Group Inc. | NEW YORK, NY | $1.7M | 166,642 |
| Walleye Capital LLC | NEW YORK, NY | $1.0M | 100,000 |
| READYSTATE ASSET MANAGEMENT LP | Chicago, IL | $1.0M | 100,000 |
| L1 Global Manager Pty Ltd | Melbourne, C3 | $1.0M | 100,000 |
| Maso Capital Partners Ltd | HONG KONG, K3 | $995K | 100,000 |
| Rangeley Capital, LLC | NEW CANAAN, CT | $327K | 55,612 |
| Robinson Capital Management, LLC | Grosse Pointe Farms, MI | $151K | 15,000 |
| UBS Group AG | Zurich, V8 | $18K | 1,763 |
| Kepos Capital LP | NEW YORK, NY | $2K | 210,000 |
| HRT FINANCIAL LP | NEW YORK, NY | $1K | 100,000 |